Trial Profile
Contributing factors on therapy with Denosumab in women with Rheumatoid Arthritis and Osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2020
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Glucocorticoids
- Indications Postmenopausal osteoporosis; Rheumatoid arthritis
- Focus Therapeutic Use
- 22 Aug 2020 Results presented at the 2020 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
- 06 Jun 2020 Results assessing Effect of Denosumab on Bone in postmenopausal Women with Rheumatoid Arthritis and Osteoporosis, presented at the 21st Annual Congress of the European League Against Rheumatism
- 15 Jul 2018 New trial record